1-866-647-3279

19

Oct 2026

What Happens When an NHP Batch Fails Quality Testing?
What Happens When an NHP Batch Fails Quality Testing?
By
At a Glance When a Natural Health Product (NHP) batch fails quality testing, manufacturers and importers must investigate the result, assess its potential impact on product safety and quality, and […] Read More >>

19

Oct 2026

What Does a Quality Assurance Person Do for Natural Health Products?
What Does a Quality Assurance Person Do for Natural Health Products?
By
At a Glance A Quality Assurance Person (QAP) is responsible for ensuring that Natural Health Products (NHPs) meet applicable quality requirements before they are made available for sale in Canada. […] Read More >>

19

Oct 2026

Can You Import NHPs into Canada Without Your Own Site Licence?
Can You Import NHPs into Canada Without Your Own Site Licence?
By
At a Glance Companies seeking to import Natural Health Products (NHPs) into Canada do not necessarily need to obtain their own Site Licence. Under Canada’s Natural Health Products Regulations, commercial […] Read More >>

16

Oct 2026

Health Canada Announces Interim Compliance Approach for NHP Monograph Labelling Updates
Health Canada Announces Interim Compliance Approach for NHP Monograph Labelling Updates
By
At a Glance Before Bulletin No. 13, Health Canada expected product licence holders to align labels affected by monograph revisions with the latest version of the monograph within three years […] Read More >>

09

Oct 2026

Bringing a Probiotic to Market in Canada: NHP, Food and Novel Food Pathways
Bringing a Probiotic to Market in Canada: NHP, Food and Novel Food Pathways
By
Abstract Bringing a probiotic product to market in Canada begins with determining how the finished product will be classified. Depending on its composition, dosage form, intended use, claims and overall […] Read More >>

05

Oct 2026

NHP GMP Inspections: What Importers Need to Demonstrate
NHP GMP Inspections: What Importers Need to Demonstrate
By
Abstract Good Manufacturing Practices (GMPs) establish the controls necessary to help ensure Natural Health Products (NHPs) are consistently manufactured, packaged, labelled, imported, distributed and stored in a manner that supports […] Read More >>

02

Sep 2026

How to Leverage a GRAS Dossier for Global Market Access
How to Leverage a GRAS Dossier for Global Market Access
By
At a Glance A GRAS dossier is often viewed as a regulatory submission prepared solely to support commercialization in the United States. In reality, a well-developed GRAS dossier can become […] Read More >>

21

Aug 2026

Health Canada Expands the List of Interchangeable Terms for NHP Labelling
Health Canada Expands the List of Interchangeable Terms for NHP Labelling
By
At a Glance Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has updated its List of Interchangeable Terms to provide greater flexibility when labelling Natural Health Products (NHPs) and […] Read More >>

19

Aug 2026

Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
By
At a Glance Live Biotherapeutic Products (LBPs) are transforming therapeutic development, with clinical programs expanding across gastrointestinal disorders, metabolic disorders, immunology, oncology, and rare conditions. Unlike conventional pharmaceutical Read More >>

14

Aug 2026

What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
By
At a Glance Vanessa’s Law, formally known as the Protecting Canadians from Unsafe Drugs Act, strengthened Health Canada’s authority to identify and respond to safety risks associated with therapeutic products […] Read More >>

14

Aug 2026

Postbiotics vs. Probiotics: Regulatory and Clinical Differences
Postbiotics vs. Probiotics: Regulatory and Clinical Differences
By
Abstract Probiotics and postbiotics are both increasingly used in microbiome-focused health products, but the regulatory and clinical considerations surrounding them can differ substantially. Probiotics depend on live microorganisms, making strain [&hellip Read More >>

14

Aug 2026

Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
By
At a Glance Health Canada has released a new guidance document, How to apply for market authorization for a non-prescription drug in Canada, providing industry with its first comprehensive roadmap […] Read More >>

06

Aug 2026

What Is NHP Stability Testing? Understanding Shelf Life, Expiry Dates, and Health Canada Requirements
What Is NHP Stability Testing? Understanding Shelf Life, Expiry Dates, and Health Canada Requirements
By
At a Glance Stability testing is the process of evaluating how the quality of a dietary supplement or Natural Health Product (NHP) changes over time under defined storage conditions. The […] Read More >>

06

Aug 2026

AI in Regulatory Intelligence and Literature Reviews: Where It Helps, and Where It Falls Short
AI in Regulatory Intelligence and Literature Reviews: Where It Helps, and Where It Falls Short
By
At a Glance AI literature review tools can help regulatory and scientific teams search, screen, organize, and summarize growing volumes of information. Their greatest value lies in narrow, repetitive tasks […] Read More >>

06

Aug 2026

Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
By
At a Glance While many commercially available probiotics have a well-documented history of safe use in healthy populations, clinical trials evaluating live biotherapeutic products (LBPs) or probiotic dietary supplements are […] Read More >>

31

Jul 2026

Cosmetic Claims in Canada: What Cosmetic Companies Can (and Can’t) Say
Cosmetic Claims in Canada: What Cosmetic Companies Can (and Can’t) Say
By
At a Glance Marketing claims are one of the most important factors determining how a cosmetic product is regulated in Canada. While cosmetics may claim to cleanse, beautify, moisturize, or […] Read More >>

21

Jul 2026

Health Canada’s New Draft Quality Guide for Natural Health Products: Open for Consultation
Health Canada’s New Draft Quality Guide for Natural Health Products: Open for Consultation
By
At a Glance Health Canada has released a draft Quality of Natural Health Products Guide for consultation, proposing the most significant update to NHP quality guidance since the finalized Good […] Read More >>

15

Jul 2026

Synbiotics: Regulatory Classification and Clinical Trial Considerations
Synbiotics: Regulatory Classification and Clinical Trial Considerations
By
Abstract Synbiotics represent an increasingly sophisticated approach to microbiome-focused products by combining live microorganisms with substrates designed to support beneficial microbial activity. However, regulatory classification and evidence requirem Read More >>

15

Jul 2026

Postbiotics: The “Non-Live” Microbe Trend Reshaping Functional Health Products
Postbiotics: The “Non-Live” Microbe Trend Reshaping Functional Health Products
By
Abstract Postbiotics are emerging as a significant new category of microbiome-focused products, offering potential advantages over traditional probiotics through improved stability, simplified manufacturing, and greater formulation flexibility. However, de Read More >>

15

Jul 2026

Does GRAS Status Matter in Canada?
Does GRAS Status Matter in Canada?
By
Abstract U.S. GRAS status is an important safety milestone, but it does not authorize an ingredient for sale in Canada. Instead, Health Canada evaluates ingredients under its own regulatory framework, […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions